 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Contact:
Jacques Cornet, VP of Business Development & Strategic Marketing
Cedara Software Corp.
905.672.2100 x-2564 jacques.cornet@cedara.com
|
|
Media Contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
(414) 977-4254
bethfj@merge.com
|
|
Attention: Business/Financial Editors:
Cedara Software Acquires Clinical Information Software Intellectual Property
- Cedara acquires assets of Paris-based medical software company
- Intellectual property to include software application named aXigate, a highly
adaptable information system designed to consolidate medical data
- Software functionality includes components for patient registration, tracking,
scheduling, reporting, coding, prescriptions, patient follow-up and more
- Acquisition provides proven information management system to compliment
Cedara’s existing portfolio of medical imaging and data management solutions.
- Acquisition furthers Merge Healthcare’s strategy in the clinical information systems
and medical imaging markets
Toronto, ON, February 1, 2006 – Cedara Software, a Merge Healthcare company
(NASDAQ: MRGE; TSX: MRG) and a leading independent developer of medical software
technologies for the global healthcare market, today announced the acquisition of assets of a
Paris-based medical software company, Axicare, acquired through court liquidation. Cedara gains exclusive ownership of aXigate, a comprehensive solution for healthcare data and workflow management.
Healthcare facilities around the world struggle to solve medical data and image
management issues on a daily basis. Most clinical information management systems operate
independently from institution wide Hospital Information Systems (HIS), resulting in islands of
information and separate patient databases. Cedara’s aXigate technology solves this problem by creating a single comprehensive patient record that can connect and manage data and medical images from existing information systems.
Cedara aXigate™ is a leading edge, fully secure, fully web-based solution for patient, medical and clinical process management. Cedara aXigate employs an open architecture, built with
XML, Java and AJAX that incorporates information from labs, radiology, the pharmacy and other
divergent areas into the hospital database. With components for patient registration, consultation, reporting, prescription, follow-up and codification, Cedara aXigate provides a folder based approach to medical information management, displaying relevant information at the click of a button to different health care professionals. Specialists can utilize Cedara aXigate’s variety of modules designed to incorporate clinical content into the patient database: from Oncology to Psychiatry, Radiology, Surgery, Neurology, Anesthesiology, OB/GYN and more. The unique clinical content can then be stored and accessed through a standard interface that provides a comprehensive portrait of medical images, diagnosis and test results. Additional modules can easily be developed by Cedara or its OEM partners using Cedara aXigate Studio, an intuitive toolkit for developers.
In the past 3 years, aXigate was installed in over 25 healthcare facilities in France, including
private clinics, care networks and several large public institutions including the University Hospital of Besançon (CHU). Applications of the technology have included clinical data management solutions, Electronic Medical Record (EMR) solutions and Hospital Information Systems (HIS).
“The underlying architecture and approach to information management in aXigate are very
impressive,” said Jacques Cornet, Vice President of Business Development and Strategic Marketing at Cedara. “This technology will provide a strong foundation on which Cedara can rapidly create new integrated information and image management solutions for areas such as pathology, oncology, biotechnology and clinical trials. For end-users and all of our OEM partners, the addition of this technology to Cedara’s portfolio opens the door to a wider array of clinical solutions beyond radiology combining image and information management. Further, this strategic technology acquisition aligns with our overall strategy as Merge Healthcare to combine our core medical imaging technologies with clinical information systems to expand our business into new markets and clinical specialties beyond radiology.”
Cedara aXigate and its clinical modules are immediately available to OEM and VAR
companies.
For further information, please contact:
Jacques Cornet, VP of Business Development & Marketing
Cedara Software Corp.
(905) 672-2100 ext. 2564
jacques.cornet@cedara.com
Media Contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
(414) 977-4254
bethfj@merge.com
Cedara Software is a Merge Healthcare company focused on the development of custom
engineered software applications and development tools for the medical imaging OEM and
International markets. Cedara software is deployed in hospitals and clinics worldwide and is
licensed by many of the world's leading medical device and healthcare information technology
companies. Cedara technologies and expertise span all the major digital imaging modalities
including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray,
mammography, ultrasound, echo-cardiology, angiography, nuclear medicine, positron emission tomography (PET) and fluoroscopy. Cedara medical imaging offerings are used in all aspects of clinical imaging workflow including the capture of a patient's digital image; the archiving, communication and manipulation of digital images; sophisticated clinical applications to analyze digital images; and the use of imaging in minimally-invasive surgery. For additional information, visit our website at www.cedara.com.
Merge Healthcare is a market leader in the development and delivery of medical imaging and
information management software and services. With over twenty years of leadership in the
medical imaging and healthcare information technology markets, Merge Healthcare provides
innovative solutions for both OEM and the end-user healthcare markets. We custom engineer
clinical and imaging applications and development tools that are on the forefront of medicine and its use of medical imaging for OEM and international customers. We develop innovative medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
All trademarks appearing in this release are the property of Cedara Software Corp.
# # #
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
